views

Reckitt Benckiser brands defy recession

RECKITT Benckiser, which makes products including Nurofen, saw profits jump by 23 per cent last year despite the recession.

The company said 2009 had been a good year and predicted growth in 2010.

Reckitt’s drug Suboxone – a heroin substitute – accounted for 16 per cent of the profits.

In the year to 31 December, operating profits jumped 23 per cent to £1.89bn – a 12 per cent increase at constant exchange rates.

The final dividend jumped 19 per cent to 57p a share, bringing the total dividend for last year to 100p – 25 per cent more than 2008.

The group, which also makes Finish dishwash products and Cillit Bang cleaners reported fourth-quarter net profit of £448m pounds compared with a consensus forecast of £447m.

Reckitt lost its exclusive licence in early October for its Suboxone heroin substitute drug and will face competition form other makers.